INTRODUCTION
A variety of agonists act on adenylate cyclase to modulate levels of the intracellular second messenger cyclic AMP. This is achieved by the coupling of activated, ligand-occupied receptors to either stimulatory (Gs) or inhibitory (G1) guanine-nucleotidebinding proteins (G-proteins) . In turn, these proteins respectively increase or decrease the activity of the catalytic unit of adenylate cyclase and thus regulate the production of cyclic AMP.
G-proteins are heterotrimers of a, , and y subunits. Activation is thought to be initiated by the exchange on the a subunit of bound GDP for free GTP. This occurs as the result of interaction of the G-protein with an activated ligand-receptor complex. Subsequent to GTP binding, the G-protein is thought to dissociate into a and fly moieties, and it is the a subunit of G. which in turn stimulates the catalytic unit. The activation is terminated by the hydrolysis of GTP by the ax subunit, GDP remaining bound to Gsa and inorganic phosphate being released. This is followed by the re-association of the a and fly subunits (for a review, see Gilman, 1987) .
Activation of adenylate cyclase can be achieved by the use of analogues of GTP such as guanosine 5'-[/Jy-imido]triphosphate (p[NH]ppG) and guanosine 5'-[y-thio]triphosphate (GTP [S] ), which cause persistent activation of G-proteins, since the terminal phosphate group is resistant to hydrolysis (Harwood et al., 1973; Londos et al., 1974) . In most systems, activation by GTP analogues occurs in the absence of receptor stimulation and this has been exploited in order to study how activated G-proteins interact with the catalytic unit of adenylate cyclase. The study of inhibition of G-proteins by GDP is complicated by its tendency to be phosphorylated to GTP in the adenylate cyclase assay system. However, this does not occur with the GDP analogue guanosine 5'-[/-thio]diphosphate (GDP [S] ). GDP [S] acts by occupying the guanine-nucleotide-binding site on G-proteins, inhibiting or reversing activation by competing with GTP and its analogues such as p [NH] ppG (Eckstein et al., 1979) .
Early experiments to assay adenylate cyclase activity in membrane preparations used millimolar concentrations of ATP (Rodbell, 1967; Krishna et al., 1968) , as constant activity of the catalytic unit of adenylate cyclase depends on the maintenance of the ATP concentration during the assay period. However, ATP is quickly degraded by the action of membrane ATPases, and so an ATP-regenerating system is routinely added, usually phosphocreatine and creatine kinase (Birnbaumer et al., 1969) . Lower concentrations of ATP, for example 100 ,M-ATP as used in most of this study, necessitate the use of a regenerating system, as the adenylate cyclase responds differently top [NH] ppG (Farndale etal., 1987) . Pre-exposure of platelet plasma membranes to p [NH]ppG (10tM) at approximately physiological levels of Mg2+
(1 mM) led to a doubling of adenylate cyclase activity, which was subsequently determined by transferring membranes from the preincubation to an assay containing ATP, cyclic AMP, phosphocreatine and creatine kinase. The development of this activity took about 20 min and was called the 'slow activation'. The activation was markedly decreased when ATP, cyclic AMP, phosphocreatine and creatine kinase were also included in the preincubation. These are the same conditions under which adenylate cyclase assays are normally carried out, where high concentrations ofcyclic AMP are included to prevent degradation of [32P] cyclic AMP by phosphodiesterase activity. The ability of p [NH] ppG to activate human platelet adenylate cyclase appears to be closely linked to the environment in which the membranes are exposed to p [NH] ppG. This effect was shown to be due to increased activity to G., and not to a decrease in G, activity (Farndale etal., 1987) .
Recently it has become evident that covalent modification by phosphorylation provides a means of modulating the activities of the different components of the adenylate cyclase complex. This mechanism of regulation could in principle be exerted at the level of the receptor, G-proteins or catalytic unit. Receptor phosphorylation has been widely documented as being involved with both homologous and heterologous desensitization (reviewed by Sibley etal., 1987) . Two possible phosphorylation sites on the catalytic unit have been identified from a cDNA sequence from bovine brain, one for cyclic AMP-dependent protein kinase and the other for protein kinase C (Krupinski et al., 1989) .
There is also some direct evidence for protein kinase C-mediated phosphorylation of the catalytic unit (Yoshimasa et al., 1987) .
Phosphorylation of G-proteins by protein kinase C has been proposed as a likely mechanism of regulation (Katada et al., 1985; Pyne et al., 1989; Sagi-Eisenberg, 1989 ). Katada et a!. (1985) proposed that phosphorylation of G, caused attenuation in the inhibition of adenylate cyclase by a variety of hormones. The kinase responsible was thought to be protein kinase C, as pretreating the platelets with phorbol esters lowered the sensitivity to inhibition. More recent work using similar conditions identified the phosphorylated species as a 40 kDa pertussistoxin-insensitive G-protein (Carlson et al., 1989) which is quite distinct from the three G, species and has been called G. (Fong et al., 1988) . However, a 41 kDa phosphoprotein has been reported to react with a Gi-specific antiserum in intact platelets (Crouch & Lapetina, 1988 proposed to be G. (Farndale et al., 1987) .
In the present study, the activation of human platelet adenylate cyclase by p[NH]ppG was investigated, to establish how the degree of activation obtained was dependent on the different conditions employed. In particular, ATP was found to be an inhibitor of activation. The kinetics of the activation process were measured in both the presence and the absence of ATP and a regenerating system of phosphocreatine and creatine kinase. Dawson et al. (1986 Daly, 1984) . Activation is thought primarily to result from direct stimulation of the catalytic unit (Seamon & Daly, 1981) , although stabilization of the interaction between G. and the catalytic unit may also occur (Wong & Martin, 1983; Yamashita et al., 1986 The effect of including ATP, cyclic AMP and the ATPregenerating system on the activation of adenylate cyclase was examined by comparing the activation kinetics under the two different sets of conditions. Fig. 2(a) shows the pooled results from four experiments in which membranes were preincubated for increasing times and the adenylate cyclase activity was then assayed. Membrane preincubations were carried out with p[NH]ppG and Mg2+ in the presence or absence of ATP (100 fM), cyclic AMP (50 /tM), phosphocreatine (8 mM) and creatine kinase (0.3 mg/ml). The inclusion of these extra components in the preincubation was clearly inhibitory, slowing the activation process and also decreasing the maximum activity obtained over this time interval. The data were then further analysed to determine whether the two activation profiles had first-order kinetics (Fig. 2b) . The data from the two types of preincubation produced good-fit straight lines, indicating that a first-order reaction scheme could be assigned to each. The values for the rate constants show that in the presence of ATP, cyclic AMP, phosphocreatine and creatine kinase, activation by p[NH]ppG and Mg2+ was severely inhibited, the half-time for the reaction increasing from 4.1 min to 7.5 min (Table 1 The effect of ATP in the absence of the regenerating system was then examined (Fig. 3 ). Membranes were preincubated with Mg2+ (1 mM) and p[NH]ppG (1O /tM). ATP (100,IM) was alse included in certain of the preincubations with and without cyclic AMP and the phosphocreatine/creatine kinase ATPregenerating system. The adenylate cyclase activity was assayed in the presence of the regenerating system at 10 mM-Mg2+ and 500 ,1M-ATP. The tiihe-dependency of the activation process was unaffected by this change in assay conditions (results not shown). The high Mg2+ concentration was present to increase the adenylate cyclase activity during the short assay and therefore the radioactivity recovered in each sample. ATP (500 #M) was employed to minimize variations in the ATP concentration of the assays. Platelet membranes in the absence of an ATPregenerating system quickly degrade ATP by the action of endogenous ATPases (results not shown). Consequently, the precise amount of ATP carried over to the assay from a preincubation without a regenerating system was unknown, so the final ATP concentration in the assay could have varied between 450 and 500 /tM. To test if this had a significant effect, membranes from control preincubations were assayed at both 450 and 500 /iM-ATP. The adenylate cyclase activity varied very little over this range of ATP concentrations, and only the data from assays with 500 ,sM-ATP are shown (Fig. 3) . The adenylate cyclase activity of samples preincubated with ATP alone were calculated at assay ATP concentrations of both 450 and 500 aM, and varied little over this range (again, only the data calculated for an assay concentration of 500 1sM-ATP are shown).
The data clearly show that ATP alone inhibited the activation adenylate cyclase activity at a particular time point, was plotted against preincubation time for the two sets of conditions and bestfit lines obtained using a least-squares method. The equations of these lines are shown in Table 1 .
of the adenylate cyclase complex. Moreover, for the first 5 min of the preincubation time course, this inhibition was indistinguishable from the effects of ATP in conjunction with the other assay components. After this time the two curves diverged. We (Farndale et al., 1987) Adenylate cyclase in human platelet membranes has been shown to be inhibited by ADP in a receptor-mediated manner, with a K1 for ADP of -0.3 /tM (Cooper & Rodbell, 1979) . The possibility was considered that the inhibition produced by ATP in both the presence and the absence of the ATP-regenerating system was caused by ADP generated by the hydrolysis of ATP.
However, this is somewhat improbable, as platelet P2 purinergic receptors are unusually specific for ADP and are antagonized by ATP (Cusack et al., 1985) . Even in the presence of the regenerating system, up to 10,1M-ADP could be generated ( (Cooper & Rodbell, 1979) . The results are shown in Fig. 4 . ADP[S] caused a slight inhibition of adenylate cyclase activity. However, the inhibition was of the same degree when ADP[S] was included in both the preincubation and the assay or solely in the assay period. In comparison with the large inhibitory effect of ATP in conjunction with the assay components, the effect of ADP[S] appeared to be insignificant. It can therefore be concluded that the inhibitory effect of ATP with or without the ATP-regenerating system was not due to the generation of ADP. Fig. 3 showed that after 5 min of preincubation the effect of ATP was dependent on the presence or absence of the other assay components. Therefore the effects on the adenylate cyclase activity of the individual assay components, namely phosphocreatine, creatine kinase and cyclic AMP, were investigated (Table 2) . Phosphocreatine alone inhibited the adenylate cyclase activity to the same degree as all four assay components together.
Creatine kinase on its own did not affect the activation of adenylate cyclase (results not shown). However, a slight increase in the degree of inhibition of adenylate cyclase activity was observed on the inclusion of creatine kinase in conjunction with phosphocreatine. This effect was most noticeable after about (Harwood et al., 1973; Lin et al., 1975; Johnson, 1980) , and in all of these cases the inhibition was shown to be due to the phosphocreatine component. We investigated the concentration-dependence of the phosphocreatine-mediated inhibition (Fig. 5) [Mg2j] in preincubation (mm) Fig. 6 Fabiato & Fabiato (1979) , and these corrected values are plotted in Fig. 6 . The data demonstrate that the inhibitory effect of phosphocreatine is not due solely to the chelation and therefore decrease in the concentration of free Mg 2+ ions. Inhibition was most marked over the concentration range 0.5-2 mMM_Mg2+. The Mg2+ concentration used routinely during this study was 1 mm, which falls within this range. Inhibition by phosphocreatine was also evident after longer periods of preincubation (results not shown).
In the absence of an ATP-regenerating system, ATP is degraded by platelet membranes (results not shown). Therefore, to examine effects of ATP over a relatively longer period of time than was possible in Fig. 3 Ross et al., 1978) . In curve C, where ATP, cyclic AMP, nsubated with only phosphocreatine and creatine kinase were present throughout, ppG and Mg2" in the no such inactivation or reversal occurred, suggesting that only ATP, cyclic AMP, under these conditions was a true equilibrium between activation ,ntrations as above), and inhibition achieved.
in the presence of
The results shown in Fig. 1 the other assay components. Fig. 8 shows the results of an experiment where membranes were preincubated for 25 min with p[NH]ppG and Mg2", after which time the activation was presumed to be maximal. The membranes were then transferred to a second preincubation, also with p{NH]ppG and Mg2" but in the presence (curve B) or absence (curve A) of ATP, cyclic AMP, phosphocreatine and creatine kinase. In a parallel incubation, occurring during the assay period, as only a slight decrease in adenylate cyclase activity occurred when GDP [S] was present solely during the 5 min assay. This lack of effect was maintained throughout preincubation (results not shown). Fig. 10(a) shown). Fig. 1O(b) is a re-plot of the data from Fig. 10(a) (Fig. 9) . Inhibition was immediate and the adenylate cyclase activity was held constant for the continuation of the experiment. This provides further evidence that the process underlying the activation is a change in activity of Gs.
A decrease in activity of Gi can be excluded, as the presence of either ADP[S] (Fig. 4) or adrenaline (Farndale et al., 1987) (Fig. 8) . It is possible that the lower maximal activity obtained in the presence of the assay components represents an equilibrium position where activatory and inhibitory forces are temporarily in balance. These results demonstrate that the mechanism of activation of platelet adenylate cyclase by p[NH]ppG is highly sensitive to the experimental conditions.
The high degree of sensitivity of the activation process is revealed by the kinetic data. In both the presence and the absence of ATP and the other assay components, the activation followed first-order kinetics (Figs. 2a and 2b) Iyengar & Birnbaumer, 1981; Jakobs et al., 1983; Farndale et al., 1987) , contrasting with the slowly changing rate of cyclic AMP generation that we have observed.
During this study, it became evident that a constituent of the ATP regenerating system, i.e. phosphocreatine, at concentrations above 1 mm, inhibited adenylate cyclase activity to a similar degree as did the full complement of assay components (Table 2 and Fig. 5 ). Similar inhibitory effects have also been observed in studies on rat liver adenylate cyclase (Harwood et (1 due to the chelation of Mg2" ions (Fig. 6) , a possible mechanism of inhibition suggested by Lin et al. (1975) .
Possible mechanisms for the inhibition by phosphocreatine include the generation of ATP from endogenous ADP and membrane-associated creatine kinase. Platelets store both ADP and ATP in dense secretory granules (Zucker & Nachmias, 1985) . The method of platelet membrane preparation that we and many others employ produces a crude plasma membrane fraction which may well be contaminated with adenine nucleotides. The Km of creatine kinase for phosphocreatine is 5 mm at pH 7.0 (Kuby et al., 1954) , which is consistent with the observed concentration-dependence of inhibition. The data in Table 2 show a small increase in the inhibition of adenylate cyclase activity when exogenous creatine kinase was added in conjunction with phosphocreatine. This suggests that the mechanism of the inhibition produced by phosphocreatine may involve creatine kinase. However, the inhibitory effect of phosphocreatine may be mediated quite differently. The possibility that phosphocreatine acts directly as a phosphate donor for protein phosphorylation cannot be excluded.
We considered the possibility that ATP-dependent inhibition of adenylate cyclase activity (Figs. 2a and 3) was mediated via guanine nucleotides present in the membrane preparation or as contaminants of ATP, phosphocreatine, creatine kinase or p[NH]ppG. Generation of GDP and/or GTP from GMP and GDP might lead to competition with p[NH]ppG, thereby blocking adenylate cyclase activation. We (Farndale et al., 1987) found no evidence for a possible inhibitory effect of GTP: the addition of 1 ,tM-GTP to a preincubation had no effect on the activation of adenylate cyclase by p[NH]ppG. It is unlikely that this concentration of GTP would be obtained from a source of contamination. The data presented in Figs. 10(a) and 10(b) show that the inhibitory effect of ATP is not in fact due to GDP production. Fig. 10(b) demonstrates that membrane preincubations in both the presence and the absence of the full ATPregenerating system had identical sensitivity to inhibition by GDP [S] . The preincubation with ATP, cyclic AMP, phosphocreatine and creatine kinase contained all the above possible sources of contaminating guanine nucleotides, and yet showed the same sensitivity to GDP [S] as did the preincubation without any of these additions.
The experimental conditions of an adenylate cyclase assay are set up to maintain the ATP concentration during the assay to prevent a decline in the rate of turnover of the catalytic unit of adenylate cyclase. These conditions also provide an environment which supports the activity ofendogenous protein kinases present in the membrane preparation (results not shown). The above results showing a decreased rate of activation of adenylate cyclase in the presence of ATP are consistent with the idea that activation may be due to a dephosphorylation event, and the inhibition observed with ATP is a result of protein phosphorylation by the action of a membrane-associated protein kinase. We (Farndale et al., 1987) have previously suggested from our results that the kinase involved may be cyclic AMPdependent protein kinase A. The lack of effect of cyclic AMP found in the present study is in contrast to the slight enhancement of ATP-induced inhibition previously observed (Farndale et al., 1987) . However, the adenylate cyclase activity observed under these experimental conditions may generate sufficient cyclic AMP to rapidly activate an endogenous protein kinase A. The possible substrates for protein phosphorylation include GS, the catalytic unit of adenylate cyclase, or a regulatory protein which interacts with the adenylate cyclase complex.
In general, platelet activation is known to be closely involved with cycles of protein phosphorylation and dephosphorylation; for example, myosin light chain, actin-binding protein and a 47 kDa protein are known to be phosphorylated during platelet activation (see Gerrard et al., 1987) . Activation of the phospholipase C-linked signal pathway and pathways producing cyclic nucleotides all cause the activation of a variety of protein kinases. The identification of protein phosphatases is less advanced in platelets, but a calcium/calmodulin-regulated phosphatase has been identified in human platelet extracts (Tallant & Wallace, 1985) . The data presented here suggest that such events may have an important role in the regulation of platelet adenylate cyclase.
